Roivant Sciences Amortization of Investment Discount and Premium decreased by 11.2% to $8.72M in Q4 2025 compared to the prior quarter. Year-over-year, this metric declined by 70.2%, from $29.27M to $8.72M.
Changes reflect shifts in the yield profile of the company's investment portfolio rather than operational performance.
This metric represents the non-cash adjustment for the amortization of premiums or the accretion of discounts on marketa...
Standard for companies with large treasury or finance divisions; peers report this as part of the reconciliation of net income to operating cash flow.
anet_investment_income_amortization| Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $25.04M | $29.27M | $15.66M | $11.06M | $9.82M | $8.72M |
| QoQ Change | — | — | — | — | — | — | — | — | +16.9% | -46.5% | -29.3% | -11.2% | -11.2% |
| YoY Change | — | — | — | — | — | — | — | — | — | — | — | -60.8% | -70.2% |